Yannick Jacques

5.3k total citations
93 papers, 4.2k citations indexed

About

Yannick Jacques is a scholar working on Immunology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Yannick Jacques has authored 93 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Immunology, 33 papers in Oncology and 22 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Yannick Jacques's work include Immune Cell Function and Interaction (45 papers), Cytokine Signaling Pathways and Interactions (24 papers) and Monoclonal and Polyclonal Antibodies Research (22 papers). Yannick Jacques is often cited by papers focused on Immune Cell Function and Interaction (45 papers), Cytokine Signaling Pathways and Interactions (24 papers) and Monoclonal and Polyclonal Antibodies Research (22 papers). Yannick Jacques collaborates with scholars based in France, Germany and United States. Yannick Jacques's co-authors include Erwan Mortier, Ariane Plet, Agnès Quéméner, Joachim Grötzinger, Patricia Vusio, Anne Godard, Laure Garrigue‐Antar, Jean Paul Soulillou, Stéphane Minvielle and Nicolas Legrand and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Yannick Jacques

92 papers receiving 4.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yannick Jacques France 34 2.7k 1.4k 1.0k 317 274 93 4.2k
Catherine H. Régnier France 23 1.9k 0.7× 830 0.6× 1.8k 1.8× 79 0.2× 255 0.9× 46 3.7k
Markus Y. Mapara United States 35 1.6k 0.6× 1.8k 1.3× 2.5k 2.5× 192 0.6× 81 0.3× 174 5.0k
Emmanuel Zorn United States 28 2.1k 0.8× 600 0.4× 816 0.8× 115 0.4× 77 0.3× 80 3.8k
Nathalie Bonnefoy France 39 2.1k 0.8× 1.3k 0.9× 1.7k 1.7× 155 0.5× 21 0.1× 102 4.4k
Stefan Hemmerich United States 30 1.2k 0.4× 650 0.5× 2.3k 2.3× 354 1.1× 277 1.0× 44 4.4k
Robert B. Henderson United Kingdom 21 1.1k 0.4× 277 0.2× 924 0.9× 183 0.6× 107 0.4× 42 2.6k
Jaime Sancho Spain 40 2.2k 0.8× 572 0.4× 1.0k 1.0× 548 1.7× 475 1.7× 107 3.8k
Keli L. Hippen United States 37 4.6k 1.7× 1.6k 1.1× 1.3k 1.3× 379 1.2× 26 0.1× 66 5.9k
Ann Ager United Kingdom 38 2.3k 0.9× 1.3k 1.0× 1.3k 1.3× 223 0.7× 33 0.1× 89 4.3k

Countries citing papers authored by Yannick Jacques

Since Specialization
Citations

This map shows the geographic impact of Yannick Jacques's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yannick Jacques with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yannick Jacques more than expected).

Fields of papers citing papers by Yannick Jacques

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yannick Jacques. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yannick Jacques. The network helps show where Yannick Jacques may publish in the future.

Co-authorship network of co-authors of Yannick Jacques

This figure shows the co-authorship network connecting the top 25 collaborators of Yannick Jacques. A scholar is included among the top collaborators of Yannick Jacques based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yannick Jacques. Yannick Jacques is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Desbois, Mélanie, Clélia Coutzac, Elie Marcheteau, et al.. (2016). IL-15 Trans-Signaling with the Superagonist RLI Promotes Effector/Memory CD8+ T Cell Responses and Enhances Antitumor Activity of PD-1 Antagonists. The Journal of Immunology. 197(1). 168–178. 51 indexed citations
2.
Bouchaud, Grégory, Erwan Mortier, Mathurin Flamant, et al.. (2010). Interleukin-15 and Its Soluble Receptor Mediate the Response to Infliximab in Patients With Crohn's Disease. Gastroenterology. 138(7). 2378–2387. 26 indexed citations
3.
Badoual, Cécile, Grégory Bouchaud, Nour El Houda Agueznay, et al.. (2008). The Soluble α Chain of Interleukin-15 Receptor: A Proinflammatory Molecule Associated with Tumor Progression in Head and Neck Cancer. Cancer Research. 68(10). 3907–3914. 73 indexed citations
4.
Mortier, Erwan, Agnès Quéméner, Patricia Vusio, et al.. (2005). Soluble Interleukin-15 Receptor α (IL-15Rα)-sushi as a Selective and Potent Agonist of IL-15 Action through IL-15Rβ/γ. Journal of Biological Chemistry. 281(3). 1612–1619. 241 indexed citations
5.
Wang, Xiaoming, et al.. (2005). Expression of a bioactive recombinant human interleukin-11 in chicken HD11 cell line. Cytokine. 30(6). 382–390. 3 indexed citations
6.
Mortier, Erwan, Jérôme Bernard, Ariane Plet, & Yannick Jacques. (2004). Natural, Proteolytic Release of a Soluble Form of Human IL-15 Receptor α-Chain That Behaves as a Specific, High Affinity IL-15 Antagonist. The Journal of Immunology. 173(3). 1681–1688. 114 indexed citations
7.
Bitard, Juliette, Sophie Daburon, Laurence Duplomb, et al.. (2003). Mutations in the Immunoglobulin-like Domain of gp190, the Leukemia Inhibitory Factor (LIF) Receptor, Increase or Decrease Its Affinity for LIF. Journal of Biological Chemistry. 278(18). 16253–16261. 19 indexed citations
8.
Wang, Xiaoming, Jean‐Marc Wilkin, Olivier Boisteau, et al.. (2002). Engineering and use of 32P‐labeled human recombinant interleukin‐11 for receptor binding studies. European Journal of Biochemistry. 269(1). 61–68. 9 indexed citations
9.
Taupin, Jean‐Luc, Patrick Legembre, Juliette Bitard, et al.. (2001). Identification of Agonistic and Antagonistic Antibodies against gp190, the Leukemia Inhibitory Factor Receptor, Reveals Distinct Roles for Its Two Cytokine-binding Domains. Journal of Biological Chemistry. 276(51). 47975–47981. 8 indexed citations
10.
Pflanz, Stefan, et al.. (1999). A fusion protein of interleukin‐11 and soluble interleukin‐11 receptor acts as a superagonist on cells expressing gp130. FEBS Letters. 450(1-2). 117–122. 43 indexed citations
11.
Blanchard, Frédéric, Laurence Duplomb, Sylvie Raher, et al.. (1999). Mannose 6-Phosphate/Insulin-like Growth Factor II Receptor Mediates Internalization and Degradation of Leukemia Inhibitory Factor but Not Signal Transduction. Journal of Biological Chemistry. 274(35). 24685–24693. 62 indexed citations
12.
Dahmen, Heike, Olivier Boisteau, Stéphane Minvielle, et al.. (1999). Definition of receptor binding sites on human interleukin‐11 by molecular modeling‐guided mutagenesis. European Journal of Biochemistry. 265(2). 645–655. 27 indexed citations
13.
Lebeau, B., John Wijdenes, Gerhard Müller‐Newen, et al.. (1997). Reconstitution of two isoforms of the human interleukin‐11 receptor and comparison of their functional properties. FEBS Letters. 407(2). 141–147. 29 indexed citations
14.
Pitard, Vincent, Jean‐Luc Taupin, Frédéric Blanchard, et al.. (1997). Production and characterization of monoclonal antibodies against the leukemia inhibitory factor low affinity receptor, gp190. Journal of Immunological Methods. 205(2). 177–190. 19 indexed citations
15.
Chérel, Michel, M. Sorel, Françoise Apiou, et al.. (1996). The Human Interleukin-11 Receptor α Gene (IL11RA): Genomic Organization and Chromosome Mapping. Genomics. 32(1). 49–53. 7 indexed citations
16.
Dantal, Jacques, M. Sorel, Michel Chérel, et al.. (1996). Antibodies directed at mouse IL-2-R ? and ? chains act in synergy to abolish T-cell proliferation in vitro and delayed type hypersensitivity reaction in vivo. Transplant International. 9(1). 46–50. 5 indexed citations
17.
Mauff, Brigitte Le, Maryvonne Hourmant, Jean‐Philippe Rougier, et al.. (1991). EFFECT OF ANTI-LFA1 (CD11a) MONOCLONAL ANTIBODIES IN ACUTE REJECTION IN HUMAN KIDNEY TRANSPLANTATION. Transplantation. 52(2). 291–295. 76 indexed citations
18.
Soulillou, Jean-Paul, Diego Cantarovich, Brigitte Le Mauff, et al.. (1990). Randomized Controlled Trial of a Monoclonal Antibody against the Interleukin-2 Receptor (33B3.1) as Compared with Rabbit Antithymocyte Globulin for Prophylaxis against Rejection of Renal Allografts. New England Journal of Medicine. 322(17). 1175–1182. 208 indexed citations
19.
Thédrez, Philippe, J Paineau, Yannick Jacques, et al.. (1989). BIODISTRIBUTION OF AN ANTI-INTERLEUKIN 2 RECEPTOR MONOCLONAL ANTIBODY IN RAT RECIPIENTS OF A HEART ALLOGRAFT, AND ITS USE AS A REJECTION MARKER IN GAMMA SCINTIGRAPHY. Transplantation. 48(3). 367–370. 10 indexed citations
20.
Jacques, Yannick & Sylvain Blanquet. (1977). Interrelation between Transfer RNA and Amino‐Acid‐Activating Sites of Methionyl Transfer RNA Synthetase from Escherichia coli. European Journal of Biochemistry. 79(2). 433–441. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Catherine H. Régnier Breakdown of academic impact, for papers by Markus Y. Mapara Breakdown of academic impact, for papers by Emmanuel Zorn Breakdown of academic impact, for papers by Nathalie Bonnefoy Breakdown of academic impact, for papers by Stefan Hemmerich Breakdown of academic impact, for papers by Robert B. Henderson Breakdown of academic impact, for papers by Jaime Sancho Breakdown of academic impact, for papers by Keli L. Hippen Breakdown of academic impact, for papers by Ann Ager
Rankless by CCL
2026